Ingrid Vanderelst

Ingrid VanderElst, leading the Life Sciences group in Ontario, consistently delivers expert guidance in the health products realm. Her counsel benefits a spectrum of clients from pharmaceutical companies to food manufacturers, focusing on regulatory intricacies and intellectual property matters.

Ingrid’s expertise shines in navigating product and establishment licensing, ensuring compliance with Good Manufacturing Practices, and providing sage advice on marketing, product recalls, and drug pricing. Her intellectual property acumen extends to patent and trademark transactions, enhancing the value and protection of technology assets for her clients.

Her unique contribution also lies in addressing privacy concerns within the health sector. Ingrid adeptly handles privacy issues related to clinical trials and commercial operations, ensuring clients' practices align with stringent privacy laws.

Holding a Ph.D. in genetics, Ingrid’s background enriches her understanding of the life sciences field. Her research on anti-metastatic chemotherapeutics and gene regulation during oncogenesis provides a solid scientific foundation to her legal practice.

Ingrid’s role extends beyond legal counsel to shaping privacy policies and navigating the complex landscape of Canada’s anti-spam law within the health sector. Her commitment to client success is evident in her hands-on approach to ensuring regulatory compliance and protecting intellectual property.

Her accolades, including recognition as Lawyer of the Year for Biotechnology Law, underscore her prominence in the field. Ingrid’s work in facilitating significant transactions like Anjac SAS’s acquisition of Apollo Healthcare Corp. and advising on the merger of Aphria Inc. and Tilray demonstrates her pivotal role in the industry.

Educationally rooted with a law degree from Osgoode Hall and a deep background in genetics, Ingrid’s comprehensive understanding of both legal and scientific aspects sets her apart. Her involvement with the Canadian and American Bar Associations reflects her dedication to her profession.

Ingrid’s impact is also felt through her contributions to the legal community, offering insights on the evolving regulatory framework for health products and privacy law. Her leadership in webinars and seminars underscores her role as a thought leader in life sciences law.

In summary, Ingrid VanderElst is a cornerstone in the legal landscape of life sciences, blending her scientific knowledge and legal expertise to navigate the complex regulatory and intellectual property challenges faced by clients in this sector.